1-16 of 16
Peter Møller
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO4-19-01: The SURVIVE-HERoes trial – a secondary adjuvant treatment intervention study with trastuzumab-deruxtecan in patients with HER2 positive/HER2 low early breast cancer and a molecular relapse, based on a positive ctDNA result

Sophia Huesmann, Franziska Mergel, Kerstin Pfister, Angelina Fink, Forca Mehmeti, Peter Möller, Tanja Fehm, Volkmar Müller, Klaus Pantel, Thomas Friedl, Andreas Hartkopf, Brigitte Rack, Wolfgang Janni
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO4-19-01.
https://doi.org/10.1158/1538-7445.SABCS23-PO4-19-01
Published: 02 May 2024
View article titled, Abstract PO4-19-01: The SURVIVE-HERoes trial – a secondary adjuvant treatment intervention study with trastuzumab-deruxtecan in patients with HER2 positive/HER2 low early breast cancer and a molecular relapse, based on a positive ctDNA result
Journal Articles

Abstract P2-01-07: Detection of early-stage breast cancer recurrence using a personalised liquid biopsy-based sequencing approach

Wolfgang Janni, Jens Huober, Sophia Huesmann, Christodoulos Pipinikas, Tatjana Braun, Volkmar Müller, Giovanni Marsico, Angelina Fink, Paula Freire-Pritchett, Karin Koretz, Charlene Knape, Amelie deGregorio, Brigitte Rack, Thomas WP Friedl, Lisa Wiesmueller, Peter Möller, Karen Howarth, Klaus Pantel, Nitzan Rosenfeld
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): P2-01-07.
https://doi.org/10.1158/1538-7445.SABCS21-P2-01-07
Published: 15 February 2022
View article titled, Abstract P2-01-07: Detection of early-stage breast cancer recurrence using a personalised liquid biopsy-based sequencing approach
Journal Articles

RINT1 Regulates SUMOylation and the DNA Damage Response to Preserve Cellular Homeostasis in Pancreatic Cancer

Frank Arnold, Johann Gout, Heike Wiese, Stephanie E. Weissinger, Elodie Roger, Lukas Perkhofer, Karolin Walter, Jeanette Scheible, Caterina Prelli Bozzo, André Lechel, Thomas J. Ettrich, Ninel Azoitei, Li Hao, Axel Fürstberger, Ewa K. Kaminska, Konstantin M.J. Sparrer, Volker Rasche, Sebastian Wiese, Hans A. Kestler, Peter Möller, Thomas Seufferlein, Pierre-Olivier Frappart, Alexander Kleger
Journal: Cancer Research
Cancer Res (2021) 81 (7): 1758–1774.
https://doi.org/10.1158/0008-5472.CAN-20-2633
Published: 01 April 2021
View article titled, RINT1 Regulates SUMOylation and the DNA Damage Response to Preserve Cellular Homeostasis in Pancreatic Cancer
Open the PDF for RINT1 Regulates SUMOylation and the DNA Damage Response to Preserve Cellular Homeostasis in Pancreatic Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 2126: Development of a precision chordoma research program

Marie Groth, Jana Kress, Matea Hajnic, Joana Marinho, Kevin Mellert, Thomas F. Barth, Peter Möller, Birgit Dreier, Andreas Plückthun, Claudia Scholl, Stefan Fröhling
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2126.
https://doi.org/10.1158/1538-7445.AM2019-2126
Published: 01 July 2019
View article titled, Abstract 2126: Development of a precision chordoma research program
Journal Articles

Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway

Adrian von Witzleben, Lukas T. Goerttler, Ralf Marienfeld, Holger Barth, André Lechel, Kevin Mellert, Michael Böhm, Marko Kornmann, Regine Mayer-Steinacker, Alexandra von Baer, Markus Schultheiss, Adrienne M. Flanagan, Peter Möller, Silke Brüderlein, Thomas F.E. Barth
Journal: Cancer Research
Cancer Res (2015) 75 (18): 3823–3831.
https://doi.org/10.1158/0008-5472.CAN-14-3270
Published: 14 September 2015
View article titled, Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway
Open the PDF for Preclinical Characterization of Novel Chordoma Cell Systems and Their Targeting by Pharmocological Inhibitors of the CDK4/6 Cell-Cycle Pathway in another window
Includes: Supplementary data
Journal Articles

Abstract 1667: Prostatitis related mitogenic stimuli cause loss of NKX3.1: Increased risk for prostate cancer

Josua Decker, Garima Jain, Philip Harazim, Tina Kießling, Peter Möller, Ralf Marienfeld
Journal: Cancer Research
Cancer Res (2014) 74 (19_Supplement): 1667.
https://doi.org/10.1158/1538-7445.AM2014-1667
Published: 01 October 2014
View article titled, Abstract 1667: Prostatitis related mitogenic stimuli cause loss of NKX3.1: Increased risk for prostate cancer
Journal Articles

Interleukin 21–Induced Granzyme B–Expressing B Cells Infiltrate Tumors and Regulate T Cells

Stefanie Lindner, Karen Dahlke, Kai Sontheimer, Magdalena Hagn, Christof Kaltenmeier, Thomas F.E. Barth, Thamara Beyer, Frank Reister, Dorit Fabricius, Ramin Lotfi, Oleg Lunov, G. Ulrich Nienhaus, Thomas Simmet, Rolf Kreienberg, Peter Möller, Hubert Schrezenmeier, Bernd Jahrsdörfer
Journal: Cancer Research
Cancer Res (2013) 73 (8): 2468–2479.
https://doi.org/10.1158/0008-5472.CAN-12-3450
Published: 15 April 2013
View article titled, Interleukin 21–Induced Granzyme B–Expressing B Cells Infiltrate Tumors and Regulate T Cells
Open the PDF for Interleukin 21–Induced Granzyme B–Expressing B Cells Infiltrate Tumors and Regulate T Cells in another window
Includes: Multimedia, Supplementary data
Journal Articles

Dynamic Mathematical Modeling of IL13-Induced Signaling in Hodgkin and Primary Mediastinal B-Cell Lymphoma Allows Prediction of Therapeutic Targets

Valentina Raia, Marcel Schilling, Martin Böhm, Bettina Hahn, Andreas Kowarsch, Andreas Raue, Carsten Sticht, Sebastian Bohl, Maria Saile, Peter Möller, Norbert Gretz, Jens Timmer, Fabian Theis, Wolf-Dieter Lehmann, Peter Lichter, Ursula Klingmüller
Journal: Cancer Research
Cancer Res (2011) 71 (3): 693–704.
https://doi.org/10.1158/0008-5472.CAN-10-2987
Published: 01 February 2011
View article titled, Dynamic Mathematical Modeling of IL13-Induced Signaling in Hodgkin and Primary Mediastinal B-Cell Lymphoma Allows Prediction of Therapeutic Targets
Open the PDF for Dynamic Mathematical Modeling of IL13-Induced Signaling in Hodgkin and Primary Mediastinal B-Cell Lymphoma Allows Prediction of Therapeutic Targets in another window
Includes: Supplementary data
Journal Articles

Abstract #2573: Expression of hTERT and Hiwi is associated with prognosis of pancreatic cancer patients

Thomas Greither, Lukasz Grochola, Peter Möller, Uwe Knippschild, Andrej Udelnow, Doris Henne-Bruns, Alexander Eckert, Peter Würl, Helge Taubert
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 2573.
Published: 01 May 2009
View article titled, Abstract #2573: Expression of hTERT and Hiwi is associated with prognosis of pancreatic cancer patients
Journal Articles

Validation of lymphoblastoid cell lines for the identification of at risk DNA repair genotypes

Alessandra Allione, Claudia Giachino, Andrea Zijno, Paola Porcedda, Simonetta Guarrera, Silvia Polidoro, Alessandra Di Gregorio, Paolo Vineis, Francesca Saini, Francesca Marcon, Bruno Garofalo, Valeria Simonelli, Flavia Barone, Anna Minoprio, Laura Narciso, Steffen Loft, Peter Moller, Ulla Vogel, Armelle Munnia, Marco Peluso, Mariarosaria D'Errico, Filomena Mazzei, Eugenia Dogliotti, Giuseppe Matullo
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 1901.
Published: 01 May 2008
View article titled, Validation of lymphoblastoid cell lines for the identification of at risk DNA repair genotypes
Journal Articles

A Sucrose-rich Diet Induces Mutations in the Rat Colon

Lars O. Dragsted, Bahram Daneshvar, Ulla Vogel, Herman N. Autrup, Håkan Wallin, Lotte Risom, Peter Møller, Anne M. Mølck, Max Hansen, Henrik E. Poulsen, Steffen Loft
Journal: Cancer Research
Cancer Res (2002) 62 (15): 4339–4345.
Published: 01 August 2002
View article titled, A Sucrose-rich Diet Induces Mutations in the Rat Colon
Open the PDF for A Sucrose-rich Diet Induces Mutations in the Rat Colon in another window
Journal Articles

Stable Nontumorigenic Phenotype of Somatic Cell Hybrids between Malignant Burkitt's Lymphoma Cells and Autologous EBV-immortalized B Cells Despite Induction of Chromosomal Breakage and Loss

Andrea Jox, Elena Taquia, Martina Vockerodt, Andreas Draube, Michael Pawlita, Peter Möller, Jörn Bullerdiek, Volker Diehl, Jürgen Wolf
Journal: Cancer Research
Cancer Res (1998) 58 (21): 4930–4939.
Published: 01 November 1998
View article titled, Stable Nontumorigenic Phenotype of Somatic Cell Hybrids between Malignant Burkitt's Lymphoma Cells and Autologous EBV-immortalized B Cells Despite Induction of Chromosomal Breakage and Loss
Open the PDF for Stable Nontumorigenic Phenotype of Somatic Cell Hybrids between Malignant Burkitt's Lymphoma Cells and Autologous EBV-immortalized B Cells Despite Induction of Chromosomal Breakage and Loss in another window
Journal Articles

Colon Carcinoma Cells Use Different Mechanisms to Escape CD95-mediated Apoptosis

Ulrike von Reyher, Jörn Sträter, Walter Kittstein, Michael Gschwendt, Peter H. Krammer, Peter Möller
Journal: Cancer Research
Cancer Res (1998) 58 (3): 526–534.
Published: 01 February 1998
View article titled, Colon Carcinoma Cells Use Different Mechanisms to Escape CD95-mediated Apoptosis
Open the PDF for Colon Carcinoma Cells Use Different Mechanisms to Escape CD95-mediated Apoptosis in another window
Journal Articles

Expression of the Natural Killer Cell-associated Antigens CD56 and CD57 in Human Neural and Striated Muscle Cells and in Their Tumors

Gunhild Mechtersheimer, Martina Staudter, Peter Möller
Journal: Cancer Research
Cancer Res (1991) 51 (4): 1300–1307.
Published: 01 February 1991
View article titled, Expression of the Natural Killer Cell-associated Antigens CD56 and CD57 in Human Neural and Striated Muscle Cells and in Their Tumors
Open the PDF for Expression of the Natural Killer Cell-associated Antigens CD56 and CD57 in Human Neural and Striated Muscle Cells and in Their Tumors in another window
Journal Articles

Influence of Major Histocompatibility Complex Class I and II Antigens on Survival in Colorectal Carcinoma

Peter Möller, Frank Momburg, Karin Koretz, Gerhard Moldenhauer, Christian Herfarth, Herwart F. Otto, Günter J. Hämmerling, Peter Schlag
Journal: Cancer Research
Cancer Res (1991) 51 (2): 729–736.
Published: 01 January 1991
View article titled, Influence of Major Histocompatibility Complex Class I and II Antigens on Survival in Colorectal Carcinoma
Open the PDF for Influence of Major Histocompatibility Complex Class I and II Antigens on Survival in Colorectal Carcinoma in another window
Journal Articles

Immunohistochemical Study of the Expression of a Mr 34,000 Human Epithelium-specific Surface Glycoprotein in Normal and Malignant Tissues

Frank Momburg, Gerhard Moldenhauer, Günter J. Hämmerling, Peter Möller
Journal: Cancer Research
Cancer Res (1987) 47 (11): 2883–2891.
Published: 01 June 1987
View article titled, Immunohistochemical Study of the Expression of a <em>M</em><sub>r</sub> 34,000 Human Epithelium-specific Surface Glycoprotein in Normal and Malignant Tissues
Open the PDF for Immunohistochemical Study of the Expression of a <em>M</em><sub>r</sub> 34,000 Human Epithelium-specific Surface Glycoprotein in Normal and Malignant Tissues in another window